Latest Regulatory Clearance News

NexGen Energy Ltd. has launched a significant dual equity financing, successfully upsizing its Australian offering and targeting combined proceeds exceeding C$1 billion. This move underscores the company's strategic capital expansion across North American and Australian markets.

NSX Limited shareholders overwhelmingly approved a scheme of arrangement for acquisition by 1001290557 Ontario Inc., a related entity of the Canadian Stock Exchange operator CNSX Markets Inc. The deal, valued at four cents per fully paid share, now awaits Federal Court approval to proceed.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

Elders Limited has secured regulatory approval to acquire Delta Agribusiness, subject to divesting six Western Australian branches, while maintaining a positive outlook for FY25 earnings.

Winsome Resources has resolved a regulatory hurdle to receive 17.65 million shares in Power Metals Corp, increasing its stake to 16.15% and reinforcing its position in critical minerals. Combined with a strong cash balance, this move strengthens Winsome’s liquidity and strategic outlook.

dorsaVi reports a striking 15-fold increase in US Physical Therapy clinic subscriptions for its ViMove+ product, driven by strong surgeon endorsements and a successful face-to-face training rollout.

Global Uranium and Snow Lake Resources have agreed to merge, creating a leading U.S.-focused uranium company valued at A$44.5 million. The deal consolidates key assets and promises enhanced exploration and development opportunities.

The U.S. FDA has lifted the clinical hold on Neurizon Therapeutics’ lead drug candidate NUZ-001, enabling its entry into a major ALS platform trial set for Q4 2025. This regulatory milestone accelerates the company’s clinical development and opens doors for broader neurodegenerative applications.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

Savannah Goldfields is on track to resume gold production at its Georgetown Gold Project by the end of October, with key maintenance and environmental approvals completed.

Seven West Media and Southern Cross Media have announced a proposed all-scrip merger to create a leading integrated media company spanning TV, audio, digital, and publishing platforms across Australia.

ReNerve Ltd is rapidly advancing its nerve repair product portfolio, with four ranges expected on the market by the end of 2025 and expanding global distribution. Clinical studies highlight significant patient benefits, supporting the company’s growth in a booming biomaterials market.